Post Exclusive: Drug companies' influence over research grows

-
A Washington Post Exclusive
Can drug research still be trusted?
The Washington Post Saturday, November 24, 2012 8:54:55 PM

Post Exclusive

Advertisement

Can drug research still be trusted?

Arguably the most prestigious medical journal in the world, the New England Journal of Medicine regularly features articles over which pharmaceutical companies and their employees can exert significant influence, a Washington Post investigation has found.

Over a year-long period ending in August, about two-thirds of the articles on new drugs published in the Journal were co-written by employees of the companies that made the drugs, a Post analysis has found.

The Journal's reliance on industry research, despite notable examples of potentially lethal bias, reflects the ability of pharmaceutical companies to shape science and influence what doctors prescribe for their patients.

Read more at:
http://www.washingtonpost.com/business/economy/as-drug-industrys-influence-over-research-grows-so-does-the-potential-for-bias/2012/11/24/bb64d596-1264-11e2-be82-c3411b7680a9_story.html







johnmhames1.lightofdiogenes@blogger.com

Comments

Post a Comment

Popular posts from this blog

FOLLOW THE MONEY - Billionaire tied to Epstein scandal funneled large donations to Ramaswamy & Democrats

-
Image
Friday, January 05, 2024 Good morning and welcome to Fox News' morning newsletter, Fox News First.  Subscribe now to get Fox News First in your email . And here's what you need to know to start your day ... FOLLOW THE MONEY  - Billionaire tied to Epstein scandal funneled large donations to Ramaswamy, Dems.  Continue reading ... BUCKLE UP  - Border state candidates issue stark warning to fellow Republicans about ceding to Dems on Ukraine.  Continue reading ... 'MALIGN INFLUENCE'  - Montana Republicans fume over university defying calls to shutter CCP-linked program.  Continue reading ... IN A 'HUFF'  - Christian influencer rips World Series champ who slid into her DMs, then deleted account.  Continue reading ... SQUAD GOALS  - Dramatic home video captures cat saving dog's life by chasing away coyotes in backyard.  Continue reading ... POLITICS 'NOTHING IS OFF THE TABLE'  - Some senators back House threats to shut down government over border security. 
Read more

Readworthy: This month’s best biographies & memoirs

-
Image
Don't miss the best new biographies & memoirs from the past month, hand-picked by our editors!   Each month, Readworthy highlights the best, most acclaimed new releases in your categories! Questions or suggestions? Let us know .   .   IN THE MEDIA Anderson Cooper says he was 'blown away' by this instant New York Times bestseller Academy Award–nominated actor and director Griffin Dunne details his unconventional coming-of-age in Hollywood — from getting fished out of the family pool by Sean Connery to surviving his sister's tragic murder. IN THE MEDIA Get on Amazon or Learn more... IN THE MEDIA The Washington Post hails this #1 New York Times bestseller as 'a classic American story' The doctor and former NIAID director who guided Americans through the COVID-19 pandemic writes candidly about his six-decade career in public health — and the political challenges he encountered along the way. IN THE MEDIA Get on Amazon or Learn more... IN THE MEDIA A dazzling
Read more

Inside J&Js bankruptcy plan to end talc lawsuits

-
Image
Women alleging J&J products caused their cancer are caught in the crossfire. Sign up for Reuters newsletters   One Essential Read One Essential Read Recommended by Kate Turton, Newsletter Editor The battle over J&J's bankruptcy plan to end talc lawsuits   Eron Evans, shown here with one of her daughters, died in 2016 of ovarian cancer at age 41. She had sued J&J alleging talc in its Baby Powder caused her disease. Johnson & Johnson is attempting to end litigation by tens of thousands of claimants who believe its talc products caused their cancer with a so-called "Texas two-step" bankruptcy. The maneuver involves offloading its talc liability onto a newly created subsidiary, which then declares Chapter 11. The goal is to use the proceeding to force all plaintiffs into one settlement – without requiring J&J itself to file bankruptcy
Read more